Deciphera Pharmaceuticals

Deciphera
Membership Level
Company Headquarters
Waltham, MA
Contact Name
Nelson Pope

Deciphera Pharmaceuticals

 

Deciphera Pharmaceuticals is focused on discovering, developing, and bringing important new medicines to patients for the treatment of cancer. Enabled by our proprietary kinase switch control inhibitor platform, our drug candidates are designed to stop cancers from growing and spreading by inhibiting mutant forms or over expression of a family of enzymes called kinases. We have built a diverse pipeline of orally administered drug candidates, including a late-stage candidate for fourth-line GIST for which we filed a New Drug Application with the U.S. FDA in December 2019.

© 2020 FLASCO | Premium Website Design by The HDG

FLASCO